title: Challenging special interest groups: whistleblowers may help. Help them!
authors.forename: Alain
authors.initials: A
authors.lastname: Braillon
mesh_terms: D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use; D016265:Conflict of Interest; D004345:Drug Industry; D057915:Drug Substitution / Q000941:ethics; D004992:Ethics, Medical; D005060:Europe; D005277:Fenfluramine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D006291:Health Policy; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000941:ethics; D011471:Prostatic Neoplasms / Q000517:prevention & control; D011785:Quality Assurance, Health Care / Q000941:ethics; D017751:Safety Management / Q000941:ethics; D056737:Safety-Based Drug Withdrawals / Q000941:ethics; D012955:Societies, Medical / Q000941:ethics; D014572:Urology / Q000941:ethics; D035642:Whistleblowing / Q000941:ethics / Q000523:psychology*
chemical_list: D001067:Appetite Depressants; D005277:Fenfluramine; C001584:benfluorex